Astellas Pharma Ltd

Lovett House, Lovett Road, Staines, Middlesex, TW18 3AZ
Telephone: +44 (0)1784 419615
Fax: +44 (0)1784 419 401
Patient Information Leaflet last updated on the eMC: 28/07/2009
PIL Advagraf 0.5mg, 1mg, 3mg & 5mg Prolonged-release hard capsules

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 28/07/2009 and displayed until Current
Reasons for adding or updating:
  • Change to Further Information section
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change of contra-indications
  • Change to storage instructions
  • Change to side-effects
  • Change to drug interactions
  • Introduction of new strength
Updated on 28/07/2009 and displayed until 28/07/2009
Reasons for adding or updating:
  • Change to Further Information section
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change of contra-indications
  • Change to storage instructions
  • Change to side-effects
  • Change to drug interactions
  • Introduction of new strength
Updated on 08/01/2009 and displayed until 28/07/2009
Reasons for adding or updating:
  • Change to side-effects
Updated on 26/09/2008 and displayed until 08/01/2009
Reasons for adding or updating:
  • Change of inactive ingredient
  • Change to date of revision
Updated on 20/08/2008 and displayed until 26/09/2008
Reasons for adding or updating:
  • Change to Marketing Authorisation Holder
  • Introduction of new pack/pack size
Updated on 12/05/2008 and displayed until 20/08/2008
Reasons for adding or updating:
  • Transfer to upgraded management system
Updated on 06/07/2007 and displayed until 12/05/2008
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
   tacrolimus


© 2009 Datapharm Communications Ltd

Go to www.medicines.org.uk